Literature DB >> 27608302

In vivo and in vitro inhibitory activity of an ethanolic extract of Sargassum fulvellum and its component grasshopper ketone on atopic dermatitis.

Bo-Kyeong Kang1, Min-Ji Kim1, Koth-Bong-Woo-Ri Kim2, Dong-Hyun Ahn3.   

Abstract

The present study investigated the effect of Sargassum fulvellum ethanol extract (SFEE) on 2,4-dinitrochlorobenzene (DNCB)-induced atopic dermatitis (AD)-like skin lesions in BALB/c mice. The severity of skin dermatitis, production of cytokines, and total IgE content were measured, and the histopathological features were analyzed. SFEE decreased the severity of DNCB-induced dermatitis and suppressed the serum levels of total immunoglobulin E (IgE), tumor necrosis factor (TNF)-α, and interleukin (IL)-4. In addition, SFEE reduced the production of IL-4, IL-5, and IL-13 in mice splenocytes. However, the levels of IL-10 and interferon (IFN)-γ significantly increased in mice sera and splenocytes. Histological examination revealed decreased dermal thickness and infiltration by mast cells after treatment with SFEE. Furthermore, grasshopper ketone, a compound isolated from SFEE, was found to significantly decrease cytokine production in concanavalin A-stimulated splenocytes from BALB/c mice with no cytotoxicity. Taken together, these results indicate that SFEE and the isolated grasshopper ketone have an inhibitory effect on AD by regulating immune mediators and cells and may be a potential effective alternative therapy for AD.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atopic dermatitis; Cytokines; Grasshopper ketone; IgE; Sargassum fulvellum

Mesh:

Substances:

Year:  2016        PMID: 27608302     DOI: 10.1016/j.intimp.2016.07.015

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  6 in total

1.  Tacrolimus nanoparticles based on chitosan combined with nicotinamide: enhancing percutaneous delivery and treatment efficacy for atopic dermatitis and reducing dose.

Authors:  Kaiyue Yu; Yixuan Wang; Tao Wan; Yuanhao Zhai; Sisi Cao; Wenyi Ruan; Chuanbin Wu; Yuehong Xu
Journal:  Int J Nanomedicine       Date:  2017-12-22

Review 2.  Pharmacological and natural products diversity of the brown algae genus Sargassum.

Authors:  Mohammed I Rushdi; Iman A M Abdel-Rahman; Hani Saber; Eman Zekry Attia; Wedad M Abdelraheem; Hashem A Madkour; Hossam M Hassan; Abeer H Elmaidomy; Usama Ramadan Abdelmohsen
Journal:  RSC Adv       Date:  2020-07-01       Impact factor: 4.036

3.  In Vitro and In Vivo Anti-Inflammatory Effects of Sulfated Polysaccharides Isolated from the Edible Brown Seaweed, Sargassum fulvellum.

Authors:  Lei Wang; Hye-Won Yang; Ginnae Ahn; Xiaoting Fu; Jiachao Xu; Xin Gao; You-Jin Jeon
Journal:  Mar Drugs       Date:  2021-05-15       Impact factor: 5.118

Review 4.  Secondary Metabolites and Biological Activity of Invasive Macroalgae of Southern Europe.

Authors:  Patrícia Máximo; Luísa M Ferreira; Paula Branco; Pedro Lima; Ana Lourenço
Journal:  Mar Drugs       Date:  2018-08-02       Impact factor: 5.118

Review 5.  Sargassum Seaweed as a Source of Anti-Inflammatory Substances and the Potential Insight of the Tropical Species: A Review.

Authors:  Puspo Edi Giriwono; Diah Iskandriati; Chin Ping Tan; Nuri Andarwulan
Journal:  Mar Drugs       Date:  2019-10-17       Impact factor: 5.118

Review 6.  Pharmaceutical and Nutraceutical Potential Applications of Sargassum fulvellum.

Authors:  Jian Liu; Sibusiso Luthuli; Qifang Wu; Mingjiang Wu; Jong-Il Choi; Haibin Tong
Journal:  Biomed Res Int       Date:  2020-10-14       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.